Table 3.
Parameter1 | Level, number of values (unit) | Definition / calculation |
---|---|---|
Duration of seropositivity | Individual camel level, single value across all sampling rounds (days). | Number of consecutive rounds when camel tested positive*10 days. |
Antibody level increase (serological indication of infection) | Individual camel level, 9 values, one for each sampling round except the first (binary event). | When, in the current sampling round, either status of camel changes from seronegative to seropositive or the OD ratio more than doubles compared to that of the previous sampling round. |
Number of positive tests | Individual camel, single value across all sampling rounds (discrete number of events from 0 to 10). | Total number of sampling rounds when the camel was found to be seropositive. |
Incidence rate2 | Whole herd, single value across all sampling rounds (cases per camel days at risk). | Number of new “cases” observed during the entire follow-up period over the cumulative sum of camel’s time at risk, with a “case” being an antibody level increase as defined above. |
Antibody level stability | Camel, single value across all sampling rounds. Only assessed for camels that tested positive at least once (binary event). | A camel is considered to exhibit antibody level stability if its OD ratio did not increase by more than 100% or decrease by more than 50% during the study period. |
Seroprevalence | Sampling round for whole herd (proportion). | Number of camels found to be seropositive at a given sampling round over the total number of camels tested at the same round. |
1 Borderline considered negative.
2 Cumulative sum of camel time at risk obtained assuming that a camel is always at risk of experiencing antibody titer increase.